|Mr. Parker H. Petit||Chairman and Chief Exec. Officer||605.7k||N/A||78|
|Mr. William Charles Taylor||Pres, Chief Operating Officer and Director||506.26k||N/A||49|
|Mr. Michael J. Senken||Chief Financial Officer, Principal Accounting Officer and VP||365.04k||N/A||59|
|Ms. Alexandra O. Haden||Gen. Counsel and Sec.||331.67k||N/A||42|
|Dr. Thomas J. Koob Ph.D.||Chief Scientific Officer||N/A||N/A||68|
MiMedx Group, Inc. develops, processes, and markets patent protected and proprietary regenerative biomaterial products and bioimplants processed from human placental tissue, skin, and bone. The company collects the donated human placental tissue and converts into a sterile product through its proprietary PURION process. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
MiMedx Group, Inc.’s ISS Governance QualityScore as of July 1, 2017 is 3. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 2; Compensation: 3.